0 citations0 references

Atomic description of the immune complex involved in heparin-induced thrombocytopenia

Nature Communications2015Vol. 6(1), pp. 8277–8277

Citations Over TimeTop 10% of 2015 papers

Zheng Cai, Serge Yarovoi, Zhiqiang Zhu, Lubica Rauova, Vincent Hayes, Tatiana Lebedeva, Qun Liu, Mortimer Poncz, Gowthami M. Arepally, Douglas B. Cines, Mark I. Greene

Abstract

Heparin-induced thrombocytopenia (HIT) is an autoimmune thrombotic disorder caused by immune complexes containing platelet factor 4 (PF4), antibodies to PF4 and heparin or cellular glycosaminoglycans (GAGs). Here we solve the crystal structures of the: (1) PF4 tetramer/fondaparinux complex, (2) PF4 tetramer/KKO-Fab complex (a murine monoclonal HIT-like antibody) and (3) PF4 monomer/RTO-Fab complex (a non-HIT anti-PF4 monoclonal antibody). Fondaparinux binds to the 'closed' end of the PF4 tetramer and stabilizes its conformation. This interaction in turn stabilizes the epitope for KKO on the 'open' end of the tetramer. Fondaparinux and KKO thereby collaborate to 'stabilize' the ternary pathogenic immune complex. Binding of RTO to PF4 monomers prevents PF4 tetramerization and inhibits KKO and human HIT IgG-induced platelet activation and platelet aggregation in vitro, and thrombus progression in vivo. The atomic structures provide a basis to develop new diagnostics and non-anticoagulant therapeutics for HIT.

Related Papers

→ Anticoagulation in children: Making the most of little patients and little evidence(2017)18 cited
Heparin induced thrombocytopenia management with bivalirudin.(2009)
Delayed-onset heparin-induced thrombocytopenia type-2 during fondiparinux (Arixtra) therapy.(2009)
→ Thrombosis due to Heparin-Induced Thrombocytopenia in Cardiac Surgery: is Fondaparinux an Effective Treatment?(2016)4 cited
→ PO-75 Efficacy and safety of fondaparinux in the management of strongly suspected heparin-induced thrombocytopenia (HIT): the key role of an early diagnosis(2010)